Federal lawmakers said Wednesday that the 340B program that allows hospitals to purchase drugs at discounted rates does not have enough oversight, leaving it susceptible to misuse.Approximately 45% of all acute-care hospitals participate in the 340B program, which has grown significantly. The Medicare Payment Advisory Commission estimates that 2,140 hospitals participated in the program in 2014, up from 583 in 2005. Program spending during that period jumped from $2.4 billion to $14 billion, according to federal data.Members of the House Energy and Commerce Committee’s Oversight and Investigations Subcommittee worry providers aren’t using their 340B savings to provide care to low-income patients.

Continue reading on Modern Helathcare